Japanese CRO CAC EXICARE Teams with Medidata to Improve Customers’ Clinical Trial Efficiency and Effectiveness Through Cloud Technology

Japanese CRO CAC EXICARE Teams with Medidata to Improve Customers’ Clinical Trial Efficiency and Effectiveness Through Cloud Technology

[Business Wire] – NEW YORK & TOKYO–(BUSINESSWIRE)– Japan-based contract research organization (CRO) CAC EXICARE has joined Medidata Solutions ‘ (NASDAQ: MDSO) Partner Program to expand its services offerings to support … more

View todays social media effects on MDSO

View the latest stocks trending across Twitter. Click to view dashboard

See who Medidata is hiring next, click here to view

Share this post